Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease.

Autor: Abdelmoaty, Mai M.1,2,3 (AUTHOR), Machhi, Jatin3 (AUTHOR), Yeapuri, Pravin1,3 (AUTHOR), Shahjin, Farah3 (AUTHOR), Kumar, Vikas4 (AUTHOR), Olson, Katherine E.3 (AUTHOR), Mosley, R. Lee3 (AUTHOR) rlmosley@unmc.edu, Gendelman, Howard E.1,3 (AUTHOR) hegendel@unmc.edu
Zdroj: Clinical & Translational Medicine. Jul2022, Vol. 12 Issue 7, p1-23. 23p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje